Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 654

1.

Sustainable cytopathology in the precision medicine era: Exploring new sources for molecular testing in thyroid cytology specimens.

Nishino M.

Cancer Cytopathol. 2019 Feb 1. doi: 10.1002/cncy.22107. [Epub ahead of print] No abstract available.

PMID:
30707506
2.

Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysis.

Tomizawa K, Sato K, Ohara S, Fujino T, Koga T, Nishino M, Kobayashi Y, Chiba M, Shimoji M, Suda K, Takemoto T, Mitsudomi T.

Surg Today. 2019 Jan 31. doi: 10.1007/s00595-019-1773-9. [Epub ahead of print]

PMID:
30706240
3.

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.

Park H, Dahlberg SE, Lydon CA, Araki T, Hatabu H, Rabin MS, Johnson BE, Nishino M.

Oncologist. 2019 Jan 29. pii: theoncologist.2018-0596. doi: 10.1634/theoncologist.2018-0596. [Epub ahead of print]

PMID:
30696724
4.

Imaging Patterns are Associated with Interstitial Lung Abnormality Progression and Mortality.

Putman RK, Gudmundsson G, Axelsson GT, Hida T, Honda O, Araki T, Yanagawa M, Nishino M, Miller ER, Eiriksdottir G, Gudmundsson EF, Tomiyama N, Honda H, Rosas IO, Washko GR, Cho MH, Schwartz DA, Gudnason V, Hatabu H, Hunninghake GM.

Am J Respir Crit Care Med. 2019 Jan 23. doi: 10.1164/rccm.201809-1652OC. [Epub ahead of print]

PMID:
30673508
5.

Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer: Improvements Using Radiomics.

Lee G, Bak SH, Lee HY, Choi JY, Park H, Lee SH, Ohno Y, Nishino M, van Beek EJR, Lee KS.

J Thorac Imaging. 2019 Jan 17. doi: 10.1097/RTI.0000000000000390. [Epub ahead of print]

PMID:
30664063
6.

Incidental non-neoplastic parenchymal findings in patients undergoing lung resection for mass lesions.

Hung YP, Hunninghake GM, Miller ER, Putman R, Nishino M, Araki T, Hatabu H, Sholl LM, Vivero M.

Hum Pathol. 2019 Jan 15. pii: S0046-8177(19)30006-1. doi: 10.1016/j.humpath.2019.01.002. [Epub ahead of print]

PMID:
30658062
7.

International symposium defines the future role of oral physicians.

Nishi M, Wilson N, Nishino M, Phantumvanit P, Songpaisan Y, Na Songkhla M, Kumagai T.

Oral Dis. 2019 Mar;25(2):634-635. doi: 10.1111/odi.13025. Epub 2019 Jan 11. No abstract available.

PMID:
30580465
8.

Calorie restriction enhances adult mouse lung stem cells function and reverses several ageing-induced changes.

Hegab AE, Ozaki M, Meligy FY, Nishino M, Kagawa S, Ishii M, Betsuyaku T.

J Tissue Eng Regen Med. 2018 Dec 18. doi: 10.1002/term.2792. [Epub ahead of print]

PMID:
30562419
9.

Perinodular Radiomic Features to Assess Nodule Microenvironment: Does It Help to Distinguish Malignant versus Benign Lung Nodules?

Nishino M.

Radiology. 2018 Dec 18:182619. doi: 10.1148/radiol.2018182619. [Epub ahead of print] No abstract available.

PMID:
30561277
10.

Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Miller ER, Putman RK, Diaz AA, Xu H, San José Estépar R, Araki T, Nishino M, Poli de Frías S, Hida T, Ross J, Coxson H, Dupuis J, O'Connor GT, Silverman EK, Rosas IO, Hatabu H, Washko G, Hunninghake GM; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) and COPDGene investigators.

Ann Am Thorac Soc. 2018 Dec 13. doi: 10.1513/AnnalsATS.201806-424OC. [Epub ahead of print]

PMID:
30543456
11.

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm.

Nishino M, Wakai S, Hida T, Dahlberg SE, Ozaki M, Hatabu H, Tachizaki H, Johnson BE.

Eur J Radiol. 2018 Dec;109:68-76. doi: 10.1016/j.ejrad.2018.10.014. Epub 2018 Oct 23.

PMID:
30527314
12.

Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.

Koga T, Kobayashi Y, Tomizawa K, Suda K, Kosaka T, Sesumi Y, Fujino T, Nishino M, Ohara S, Chiba M, Shimoji M, Takemoto T, Suzuki M, Jänne PA, Mitsudomi T.

Lung Cancer. 2018 Dec;126:72-79. doi: 10.1016/j.lungcan.2018.10.019. Epub 2018 Oct 17.

PMID:
30527195
13.

Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro.

Nishino M, Suda K, Kobayashi Y, Ohara S, Fujino T, Koga T, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T.

Lung Cancer. 2018 Dec;126:149-155. doi: 10.1016/j.lungcan.2018.10.026. Epub 2018 Oct 31.

PMID:
30527179
14.

Imaging of Histiocytosis in the Era of Genomic Medicine.

Park H, Nishino M, Hornick JL, Jacobsen ED.

Radiographics. 2019 Jan-Feb;39(1):95-114. doi: 10.1148/rg.2019180054. Epub 2018 Nov 30.

PMID:
30500304
15.

Different Neoatherosclerosis Patterns in Drug-Eluting- and Bare-Metal Stent Restenosis - Optical Coherence Tomography Study.

Nakamura D, Yasumura K, Nakamura H, Matsuhiro Y, Yasumoto K, Tanaka A, Matsunaga-Lee Y, Yano M, Yamato M, Egami Y, Shutta R, Sakata Y, Tanouchi J, Nishino M.

Circ J. 2019 Jan 25;83(2):313-319. doi: 10.1253/circj.CJ-18-0701. Epub 2018 Nov 29.

16.

Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.

Nishino M, Hatabu H, Hodi FS.

Radiology. 2019 Jan;290(1):9-22. doi: 10.1148/radiol.2018181349. Epub 2018 Nov 20.

PMID:
30457485
18.

[Analysis of Patients Who Received Nutritional Support and the Enhanced Recovery after Surgery(ERAS)Protocol after Esophagectomy].

Kawada J, Nishino M, Hata T, Tanizaki K, Ogino T, Hoshino H, Okano M, Nagai K, Kim Y, Okuyama M, Tsujinaka T, Imamoto H.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1524-1526. Japanese.

PMID:
30382066
19.

The Global Naturalized Alien Flora (GloNAF) database.

van Kleunen M, Pyšek P, Dawson W, Essl F, Kreft H, Pergl J, Weigelt P, Stein A, Dullinger S, König C, Lenzner B, Maurel N, Moser D, Seebens H, Kartesz J, Nishino M, Aleksanyan A, Ansong M, Antonova LA, Barcelona JF, Breckle SW, Brundu G, Cabezas FJ, Cárdenas D, Cárdenas-Toro J, Castaño N, Chacón E, Chatelain C, Conn B, de Sá Dechoum M, Dufour-Dror JM, Ebel AL, Figueiredo E, Fragman-Sapir O, Fuentes N, Groom QJ, Henderson L, Inderjit, Jogan N, Krestov P, Kupriyanov A, Masciadri S, Meerman J, Morozova O, Nickrent D, Nowak A, Patzelt A, Pelser PB, Shu WS, Thomas J, Uludag A, Velayos M, Verkhosina A, Villaseñor JL, Weber E, Wieringa JJ, Yazlık A, Zeddam A, Zykova E, Winter M.

Ecology. 2019 Jan;100(1):e02542. doi: 10.1002/ecy.2542. Epub 2018 Dec 5.

PMID:
30341991
20.

Early stage periarticular injection during total knee arthroplasty may provide a better postoperative pain relief than late-stage periarticular injection: a randomized-controlled trial.

Tsukada S, Kurosaka K, Maeda T, Iida A, Nishino M, Hirasawa N.

Knee Surg Sports Traumatol Arthrosc. 2018 Sep 20. doi: 10.1007/s00167-018-5140-y. [Epub ahead of print]

PMID:
30238239
21.

Tumor Response Assessment for Precision Cancer Therapy: Response Evaluation Criteria in Solid Tumors and Beyond.

Nishino M.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):1019-1029. doi: 10.1200/EDBK_201441. Review.

PMID:
30231378
22.

Diagnosis Please Certificates of Recognition Awarded to Three Individuals and to International and North American Radiology Resident Groups.

Nishino M, Bluemke DA.

Radiology. 2018 Nov;289(2):277-279. doi: 10.1148/radiol.2018181490. Epub 2018 Sep 18. No abstract available.

PMID:
30226457
23.

Updates in Thyroid Cytology.

Nishino M, Krane JF.

Surg Pathol Clin. 2018 Sep;11(3):467-487. doi: 10.1016/j.path.2018.05.002. Review.

PMID:
30190135
24.

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.

Sabari JK, Leonardi GC, Shu CA, Umeton R, Montecalvo J, Ni A, Chen R, Dienstag J, Mrad C, Bergagnini I, Lai WV, Offin M, Arbour KC, Plodkowski AJ, Halpenny DF, Paik PK, Li BT, Riely GJ, Kris MG, Rudin CM, Sholl LM, Nishino M, Hellmann MD, Rekhtman N, Awad MM, Drilon A.

Ann Oncol. 2018 Oct 1;29(10):2085-2091. doi: 10.1093/annonc/mdy334.

PMID:
30165371
25.

Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer.

Horita Y, Nishino M, Sugimoto S, Kida A, Mizukami A, Yano M, Arihara F, Matsuda K, Matsuda M, Sakai A.

Anticancer Drugs. 2019 Jan;30(1):98-104. doi: 10.1097/CAD.0000000000000691.

PMID:
30124494
26.
27.

Crystalline functionalized endohedral C60 metallofullerides.

Nakagawa A, Nishino M, Niwa H, Ishino K, Wang Z, Omachi H, Furukawa K, Yamaguchi T, Kato T, Bandow S, Rio J, Ewels C, Aoyagi S, Shinohara H.

Nat Commun. 2018 Aug 6;9(1):3073. doi: 10.1038/s41467-018-05496-8.

28.

Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer.

Bahcall M, Awad MM, Sholl LM, Wilson FH, Xu M, Wang S, Palakurthi S, Choi J, Ivanova EV, Leonardi GC, Ulrich BC, Paweletz CP, Kirschmeier PT, Watanabe M, Baba H, Nishino M, Nagy RJ, Lanman RB, Capelletti M, Chambers ES, Redig AJ, VanderLaan PA, Costa DB, Imamura Y, Jänne PA.

Clin Cancer Res. 2018 Dec 1;24(23):5963-5976. doi: 10.1158/1078-0432.CCR-18-0876. Epub 2018 Aug 2.

PMID:
30072474
29.

Cutaneous Hypesthesia and Kneeling Ability After Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Anterolateral and Anteromedial Skin Incision.

Tsukada S, Kurosaka K, Nishino M, Hirasawa N.

J Arthroplasty. 2018 Oct;33(10):3174-3180. doi: 10.1016/j.arth.2018.06.010. Epub 2018 Jun 19.

30.

No Clinically Important Difference in Pain Scores After THA Between Periarticular Analgesic Injection and Placebo: A Randomized Trial.

Hirasawa N, Kurosaka K, Nishino M, Nakayama T, Matsubara M, Tsukada S.

Clin Orthop Relat Res. 2018 Sep;476(9):1837-1845. doi: 10.1097/CORR.0000000000000374.

PMID:
29939894
31.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

PMID:
29773717
32.

Initial result of an angioscopy-guided wire crossing technique under continuous saline infusion for chronic total occlusion in femoropopliteal disease.

Yano M, Yasumura K, Yasumoto K, Tanaka A, Mori N, Nakamura D, Egami Y, Shutta R, Tanouchi J, Nishino M.

EuroIntervention. 2019 Jan 20;14(13):1416-1419. doi: 10.4244/EIJ-D-18-00031. No abstract available.

33.

Expanded acceptance of acute exacerbation of nonspecific interstitial pneumonia, including 7 additional cases with detailed clinical pathologic correlation.

Miyamoto A, Sharma A, Nishino M, Mino-Kenudson M, Matsubara O, Mark EJ.

Pathol Int. 2018 Jul;68(7):401-408. doi: 10.1111/pin.12676. Epub 2018 May 3.

PMID:
29726062
34.

Comparison of two instructions for deep breathing exercise: non-specific and diaphragmatic breathing.

Yokogawa M, Kurebayashi T, Ichimura T, Nishino M, Miaki H, Nakagawa T.

J Phys Ther Sci. 2018 Apr;30(4):614-618. doi: 10.1589/jpts.30.614. Epub 2018 Apr 20.

35.

[A Case of Advanced Esophageal Cancer Successfully Treated with Multidisciplinary Therapy].

Kawada J, Nishino M, Hata T, Ogino T, Okawa M, Hoshino H, Okano M, Nagai K, Kakita N, Kim Y, Okuyama M, Tsujinaka T.

Gan To Kagaku Ryoho. 2018 Apr;45(4):703-705. Japanese.

PMID:
29650841
36.

[A Case of Effective Palliative Care with CART for Refractory Ascites Associated with Cancerous Peritonitis of Gastric Cancer].

Kawada J, Nishino M, Hata T, Ogino T, Hoshino H, Okano M, Nagai K, Kim Y, Okuyama M, Tsujinaka T.

Gan To Kagaku Ryoho. 2018 Apr;45(4):700-702. Japanese.

PMID:
29650840
37.

An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib.

Abravanel DL, Nishino M, Sholl LM, Ambrogio C, Awad MM.

J Thorac Oncol. 2018 Aug;13(8):e131-e133. doi: 10.1016/j.jtho.2018.03.026. Epub 2018 Apr 6. No abstract available.

PMID:
29631033
38.

Sarcoid-Like Granulomatosis of the Lung Related to Immune-Checkpoint Inhibitors: Distinct Clinical and Imaging Features of a Unique Immune-Related Adverse Event.

Nishino M, Sholl LM, Awad MM, Hatabu H, Armand P, Hodi FS.

Cancer Immunol Res. 2018 Jun;6(6):630-635. doi: 10.1158/2326-6066.CIR-17-0715. Epub 2018 Apr 5.

PMID:
29622582
39.

Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.

Nagakura KI, Yanagida N, Sato S, Nishino M, Asaumi T, Ogura K, Ebisawa M.

Pediatr Allergy Immunol. 2018 Aug;29(5):512-518. doi: 10.1111/pai.12898. Epub 2018 May 10.

PMID:
29603410
40.

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018.

Ozaki Y, Katagiri Y, Onuma Y, Amano T, Muramatsu T, Kozuma K, Otsuji S, Ueno T, Shiode N, Kawai K, Tanaka N, Ueda K, Akasaka T, Hanaoka KI, Uemura S, Oda H, Katahira Y, Kadota K, Kyo E, Sato K, Sato T, Shite J, Nakao K, Nishino M, Hikichi Y, Honye J, Matsubara T, Mizuno S, Muramatsu T, Inohara T, Kohsaka S, Michishita I, Yokoi H, Serruys PW, Ikari Y, Nakamura M; Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT).

Cardiovasc Interv Ther. 2018 Apr;33(2):178-203. doi: 10.1007/s12928-018-0516-y. Epub 2018 Mar 29.

41.

Rare Case of Giant Non-Thrombosed Coronary Artery Aneurysm at the Left Anterior Descending Coronary Artery.

Matsuhiro Y, Yasumoto K, Yasumura K, Tanaka A, Mori N, Nakamura D, Yano M, Egami Y, Shutta R, Tanouchi J, Nishino M.

Circ J. 2018 Jul 25;82(8):2213-2214. doi: 10.1253/circj.CJ-17-1028. Epub 2018 Feb 16. No abstract available.

42.

Global rise in emerging alien species results from increased accessibility of new source pools.

Seebens H, Blackburn TM, Dyer EE, Genovesi P, Hulme PE, Jeschke JM, Pagad S, Pyšek P, van Kleunen M, Winter M, Ansong M, Arianoutsou M, Bacher S, Blasius B, Brockerhoff EG, Brundu G, Capinha C, Causton CE, Celesti-Grapow L, Dawson W, Dullinger S, Economo EP, Fuentes N, Guénard B, Jäger H, Kartesz J, Kenis M, Kühn I, Lenzner B, Liebhold AM, Mosena A, Moser D, Nentwig W, Nishino M, Pearman D, Pergl J, Rabitsch W, Rojas-Sandoval J, Roques A, Rorke S, Rossinelli S, Roy HE, Scalera R, Schindler S, Štajerová K, Tokarska-Guzik B, Walker K, Ward DF, Yamanaka T, Essl F.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2264-E2273. doi: 10.1073/pnas.1719429115. Epub 2018 Feb 5.

43.

EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib.

Kobayashi Y, Fujino T, Nishino M, Koga T, Chiba M, Sesumi Y, Ohara S, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T.

J Thorac Oncol. 2018 May;13(5):727-731. doi: 10.1016/j.jtho.2018.01.009. Epub 2018 Feb 2.

PMID:
29410323
44.

Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis.

Kobayashi K, Nakachi I, Naoki K, Satomi R, Nakamura M, Inoue T, Tateno H, Sakamaki F, Sayama K, Terashima T, Koh H, Abe T, Nishino M, Arai D, Yasuda H, Kawada I, Soejima K, Betsuyaku T; Keio Lung Oncology Group (KLOG).

Clin Lung Cancer. 2018 May;19(3):e349-e358. doi: 10.1016/j.cllc.2018.01.001. Epub 2018 Jan 5.

PMID:
29398578
45.

Beneficial effects of restrictive annuloplasty on subvalvular geometry in patients with functional mitral regurgitation and advanced cardiomyopathy.

Kainuma S, Funatsu T, Kondoh H, Yokota T, Maeda S, Shudo Y, Matsue H, Nishino M, Daimon T, Toda K, Sawa Y, Taniguchi K.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):630-638.e1. doi: 10.1016/j.jtcvs.2017.11.090. Epub 2017 Dec 18.

PMID:
29395191
46.

[A Case of Resected Superior Sulcus Tumor with Pathological Complete Response after Trimodality Therapy].

Nishino M, Tomizawa K, Ohara S, Fujino T, Sesumi Y, Koga T, Sato K, Kobayashi Y, Chiba M, Shimoji M, Takemoto T, Mitsudomi T.

Gan To Kagaku Ryoho. 2018 Jan;45(1):103-105. Japanese.

PMID:
29362322
47.

Risk Factors and Clinical Features in Cashew Nut Oral Food Challenges.

Inoue T, Ogura K, Takahashi K, Nishino M, Asaumi T, Yanagida N, Sato S, Ebisawa M.

Int Arch Allergy Immunol. 2018;175(1-2):99-106. doi: 10.1159/000486120. Epub 2018 Jan 18.

PMID:
29342459
48.

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy.

Hodi FS, Ballinger M, Lyons B, Soria JC, Nishino M, Tabernero J, Powles T, Smith D, Hoos A, McKenna C, Beyer U, Rhee I, Fine G, Winslow N, Chen DS, Wolchok JD.

J Clin Oncol. 2018 Mar 20;36(9):850-858. doi: 10.1200/JCO.2017.75.1644. Epub 2018 Jan 17.

PMID:
29341833
49.

Oral Immunotherapy in Japanese Children with Anaphylactic Peanut Allergy.

Nagakura KI, Sato S, Yanagida N, Nishino M, Asaumi T, Ogura K, Ebisawa M.

Int Arch Allergy Immunol. 2018;175(3):181-188. doi: 10.1159/000486310. Epub 2018 Jan 16.

PMID:
29339650
50.

Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules.

Nishino M, Nikiforova M.

Arch Pathol Lab Med. 2018 Apr;142(4):446-457. doi: 10.5858/arpa.2017-0174-RA. Epub 2018 Jan 16. Review.

PMID:
29336606

Supplemental Content

Loading ...
Support Center